These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38077635)

  • 1. Features of synchronous and metachronous dual primary gastric and colorectal cancer.
    Lin YJ; Chen HX; Zhang FX; Hu XS; Huang HJ; Lu JH; Cheng YZ; Peng JS; Lian L
    World J Gastrointest Oncol; 2023 Nov; 15(11):1864-1873. PubMed ID: 38077635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous?
    Watanabe M; Kochi M; Fujii M; Kaiga T; Mihara Y; Funada T; Tamegai H; Shimizu H; Takayama T
    Am J Clin Oncol; 2012 Oct; 35(5):407-10. PubMed ID: 21659834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor size is an independent risk predictor for metachronous colorectal cancer.
    Kato T; Alonso S; Muto Y; Perucho M; Rikiyama T
    Oncotarget; 2016 Apr; 7(14):17896-904. PubMed ID: 26910116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for metachronous adenoma in patients with stage I/II colorectal cancer after radical surgery.
    Song W; Chen Z; Zheng Z; Zhang Z; Chen Y; He X; Lan P; Hu J; He X
    J Gastrointest Oncol; 2021 Apr; 12(2):535-543. PubMed ID: 34012647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
    Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual primary gastric and colorectal cancer: A complex challenge in surgical oncology.
    Marano L
    World J Gastrointest Oncol; 2023 Dec; 15(12):2049-2052. PubMed ID: 38173432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Impact of Synchronous and Metachronous Other Primary Cancer in Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Hashimoto I; Kano K; Hara K; Cho H; Morita J; Segami K; Onodera A; Endo K; Onuma S; Oshima T; Yukawa N; Rino Y
    In Vivo; 2022; 36(5):2514-2520. PubMed ID: 36099136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer.
    Yoon SN; Oh ST; Lim SB; Kim TW; Kim JH; Yu CS; Kim JC
    World J Surg; 2010 Sep; 34(9):2168-76. PubMed ID: 20532772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of synchronous and metachronous multiple primary lung cancers: systematic review and meta-analysis.
    Jiang L; He J; Shi X; Shen J; Liang W; Yang C; He J
    Lung Cancer; 2015 Mar; 87(3):303-10. PubMed ID: 25617985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
    Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
    Huang CW; Tsai HL; Chen YT; Huang CM; Ma CJ; Lu CY; Kuo CH; Wu DC; Chai CY; Wang JY
    BMC Cancer; 2013 Dec; 13():599. PubMed ID: 24330663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer.
    Kunitomo A; Ouchi A; Komori K; Kinoshita T; Sato Y; Abe T; Ito S; Sano T; Shimizu Y
    Ann Surg Oncol; 2023 Dec; 30(13):8501-8508. PubMed ID: 37658266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and prognostic nomogram analysis of patients with dual primary cancers with first gastric cancer: a retrospective study in China.
    Wang B; Liu L
    PeerJ; 2023; 11():e15278. PubMed ID: 37151300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer.
    Pozza A; Ruffolo C; Fiorot A; Padoan L; Erroi F; Massani M; Caratozzolo E; Bonariol L; Ferrara F; Norberto L; Castoro C; Bassi N; Scarpa M
    Acta Chir Belg; 2016 Aug; 116(4):225-230. PubMed ID: 27426670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of disease-free interval in colorectal cancer: Is it time?
    Birgin E; Doyon F; Burkert J; Téoule P; Rasbach E; Rahbari M; Reissfelder C; Betzler A; Rahbari NN
    Eur J Surg Oncol; 2022 Sep; 48(9):2032-2038. PubMed ID: 35738980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.
    Kim C; Chon H; Kang B; Kim K; Jeung HC; Chung H; Noh S; Rha S
    BMC Cancer; 2013 Aug; 13():394. PubMed ID: 23967865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.